Smartphone Application for Smoking Cessation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02134509

Enrollment

511

Registered

2014-05-09

Start date

2014-10-31

Completion date

2016-06-30

Last updated

2020-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

Cigarette smoking

Brief summary

The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.

Detailed description

In this randomized control trial, subjects will be randomly assigned to receive one of two treatments: (1) a standard smartphone application to support smokers working to become quit-free, or (2) the tested intervention, an app that trains behavioral strategies for smoking cessation. The primary endpoint of interest will be 1-week point prevalence abstinence at end of treatment, and at 3 and 6 months follow-up for individuals.

Interventions

BEHAVIORALExperimental App

It is comprised of twenty-two modules of 10-15 minutes each, designed to teach behavioral strategies for smoking cessation using psychoeducation-based audio and videos, animations to reinforce key concepts, and in vivo exercises. In addition, 5 bonus modules become available upon completion of earlier modules; these may be accessed for additional practices to bolster other modules

BEHAVIORALActive Comparator App

It is comprised of 6 prompts per day asking individuals about their experience, behavior, and smoking habits, for 22-days.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Smoke 5+ cigarettes/day * \< 3 months abstinence in the past year * Have a smartphone * Score greater than or equal to 8 of 10 on the Contemplation Ladder (Biener & Abrams, 1991)

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Point prevalence abstinence at 6 months	6 months after beginning treatment	Subjects will be assessed for smoking abstinence at a 6-month follow-up.

Secondary

Measure	Time frame	Description
Point prevalence abstinence at 3 months	3 months after beginning treatment	Subjects will be assessed for smoking abstinence at a 3-month follow-up.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026